Efficacy and Safety of Intensive Antiplatelet Therapy With Prasugrel from TRITON-TIMI 38 in a Core Clinical Cohort Defined by Worldwide Regulatory Agencies-Reference-Cited by-同舟云学术

Efficacy and Safety of Intensive Antiplatelet Therapy With Prasugrel from TRITON-TIMI 38 in a Core Clinical Cohort Defined by Worldwide Regulatory Agencies

Published:2011-10 Issue:7 Volume:108 Page:905-911
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Wiviott Stephen D.,Desai Nihar,Murphy Sabina A.,Musumeci Guiseppe,Ragosta Michael,Antman Elliott M.,Braunwald Eugene

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference18 articles.

1. Prasugrel: a novel thienopyridine antiplatelet agent;Jakubowski;Cardiovasc Drug Rev,2007

2. Prasugrel Compared With High Loading- and Maintenance-Dose Clopidogrel in Patients With Planned Percutaneous Coronary Intervention

3. Prasugrel versus Clopidogrel in Patients with Acute Coronary Syndromes;Wiviott;N Engl J Med,2007

4. Weighing benefits and risks—the FDA's review of prasugrel;Unger;N Engl J Med,2009

5. Population pharmacokinetic analyses to evaluate the influence of intrinsic and extrinsic factors on exposure of prasugrel active metabolite in TRITON-TIMI 38;Wrishko;J Clin Pharmacol,2009

Cited by 55 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Surgical transmitral thrombectomy to prevent recurrent stroke in acute myocardial infarction;Cardiovascular Revascularization Medicine;2022-08

2. Current Perspectives on Antithrombotic Therapy for the Treatment of Acute Coronary Syndrome;International Journal of General Medicine;2022-03

3. Antiplatelet agents for chronic kidney disease;Cochrane Database of Systematic Reviews;2022-02-28

4. Management of ST Elevation Myocardial Infarction (STEMI) in Different Settings;International Journal of Angiology;2021-03

5. Pharmacodynamic Profile and Prevalence of Bleeding Episode in East Asian Patients with Acute Coronary Syndromes Treated with Prasugrel Standard-Dose versus De-escalation Strategy: A Randomized A-MATCH Trial;Thrombosis and Haemostasis;2021-01-05